Bright Minds Biosciences has debuted glowing phase 2 results for its lead anti-seizure asset, giving the biotech’s stock a ...

Classical psychedelics act on a surprisingly broad range of brain receptors, not just the serotonin receptor long associated with their hallucinogenic effects, according to new research published in ...

Activation of the serotonin receptor, 5-HT1A, has been shown to regulate mood and cognition. The receptor is the primary target of buspirone, vilazodone, and gepirone, FDA-approved medications for the ...

UC Davis researchers have developed a new method that uses light to transform amino acids - the building blocks of proteins - ...

In a discovery that could guide the development of next-generation antidepressants and antipsychotic medications, researchers at the Icahn School of Medicine at Mount Sinai have developed new insights ...